

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
He rongoā whakahau a Tildrakizumab e āwhina ana ki te rongoā i te psoriasis pātea ngawari ki te kaha i roto i ngā pakeke. E mahi ana tēnei rongoā werohia mā te whai i ngā pūmua motuhake i roto i tō pūnaha ārai mate e whai wāhi ana ki ngā tohumate psoriasis.
Mēnā kei te raru koe i ngā pātea psoriasis e hipoki ana i te wāhi nui o tō tinana, kāore rānei i pai te urupare ki ētahi atu rongoā, ka tūtohu pea tō tākuta i te tildrakizumab hei wāhanga o tō mahere rongoā. I hangaia hei āwhina i te whakawātea i tō kiri me te whakaiti i te mumura e pā ana ki aua pātea unuhā, unuhā.
He momo rongoā a Tildrakizumab e kīia ana he paturopi monoclonal e whai ana i te psoriasis. No te akomanga rongoā e mōhiotia ana ko te biologics, i hangaia mai i ngā pūtau ora, kaua i ngā matū.
Ka tae mai tēnei rongoā hei syringe kua whakakiia, pene rānei e werohia ana e koe i raro i tō kiri (subcutaneously). Ko te ingoa waitohu mō te tildrakizumab ko Ilumya, ā, kua whakaaetia mō te rongoā i te psoriasis pātea ngawari ki te kaha i roto i ngā pakeke e tika ana mō te rongoā pūnaha, te phototherapy rānei.
Kāore i rite ki ngā kirīmi kaupapa, ngā pire rānei, e mahi ana te tildrakizumab mai i roto i tō tinana ki te whakatika i te take pūtake o te mumura psoriasis. E kiia ana he rongoā whāinga nā te mea e arotahi ana ki ngā ara motuhake o te pūnaha ārai mate e whai wāhi ana ki te whanaketanga psoriasis.
Ko te tildrakizumab te mea nui e whakamahia ana hei rongoā i te psoriasis pātea ngawari ki te kaha i roto i ngā pakeke. Ko te tikanga tēnei ka whakahaua ina hipoki ana tō psoriasis i te wāhi nui o tō tinana, e pā ana rānei ki tō kounga o te oranga.
Ka tohutohu pea tō tākuta i te tildrakizumab mēnā he psoriasis tōna kāore i pai te urupare ki ngā rongoā ā-rohe pēnei i te kirīmi me te hinu. He kōwhiringa anō hoki mēnā he kaitono koe mō te rongoā pūnaha, arā, ngā rongoā e mahi ana puta noa i tō tinana katoa, kaua ko te mata o te kiri anake.
I hangaia te rongoā mō te psoriasis pātai, te momo psoriasis e tino kitea ana. Ko tēnei momo ka puta ngā pāti whero, kua ara ake, he mea hipoki ki ngā unahi hiriwa ka puta ki hea rānei i tō tinana engari ka pā ki ō tūātae, ngā turi, te kiri o te mahunga, me te tuara o raro.
Ka mahi a Tildrakizumab mā te aukati i tētahi pūmua motuhake e kīia ana ko te interleukin-23 (IL-23) i roto i tō pūnaha ārai mate. He mahi nui tēnei pūmua ki te whakaoho i te mumura me te tipu tere o ngā pūtau kiri e whakaatu ana i te psoriasis.
Whakaarohia te IL-23 he karere e kī ana ki tō pūnaha ārai mate kia hanga mumura i tō kiri. Mā te aukati i tēnei karere, ka āwhina a tildrakizumab ki te whakaiti i te urupare ārai mate e kaha rawa ana e arahi ana ki ngā tohu psoriasis.
E kiia ana he kaha ngāwari tēnei rongoā i waenga i ngā rongoā psoriasis. He nui ake te whāinga i ētahi rongoā pūnaha tawhito, ko te tikanga he iti ake ngā pānga ki tō pūnaha ārai mate whānui i te wā e whai hua tonu ana mō ngā tohu psoriasis.
Ka āwhina te mahi aukati ki te whakaroa i te huri tere o ngā pūtau kiri e hanga ana i aua pāti matotoru, unahi. I te roanga o te wā, ka taea e tēnei te arahi ki te kiri mārama ake me te whakaiti i te mumura i ngā wāhi e pā ana.
Ka tukuna a Tildrakizumab hei werohanga i raro i tō kiri, te tikanga i tō huha, te puku, te ringa rānei. Mā tō kaiwhakarato hauora koe e ako me pēhea te werohanga i a koe anō, ka taea rānei e koe te mahi i tētahi tari rongoā.
Ka tae mai te rongoā i roto i te pūwero kua whakakiia, i te pūwero pene rānei hei whakamāmā i te werohanga whaiaro. Me tuku te rongoā kia tae ki te pāmahana rūma i mua i te werohanga, ā, tata ki te 30 meneti te roa i muri i te tangohanga mai i te pouaka whakamātao.
Ka taea e koe te tango tildrakizumab me te kore kai rānei, nā te mea ka werohia, kaua e tangohia mā te waha. Heoi, me huri ngā wāhi werohanga hei aukati i te riri o te kiri, me te karo i te werohanga ki ngā wāhi e ngawari ana tō kiri, e pā ana ki te pānga, e pā ana rānei ki te psoriasis.
I mua i ia werohanga, horoia ō ringa kia tino mā, ka horoi i te wāhi werohanga ki te waipiro. Me mōhio ki te whakakore i ngā ngira me ngā pūwero kua whakamahia i roto i te ipu koi.
Ka tīmata te nuinga o te tangata ki te horopeta tuatahi, ka whai i tētahi atu horopeta 4 wiki i muri mai, ka haere tonu ki ngā horopeta ia 12 wiki. Māu e whakatau te hōtaka tika mō tō āhuatanga motuhake.
He āhuatanga mau tonu te Psoriasis, ko te tikanga ko te tildrakizumab he rongoā wā roa. He maha ngā tāngata e haere tonu ana ki te tango mō ngā marama, ngā tau rānei hei pupuri i te kiri mārama me te aukati i ngā tohu psoriasis kia hoki mai.
Ka tīmata pea koe ki te kite i ngā whakapainga i tō kiri i roto i ngā wiki tuatahi, engari ka roa pea te 12-16 wiki kia kite i ngā pānga katoa. Māu e aroturuki tō ahunga whakamua, ā, ka whakatika pea tō mahere rongoā i runga i te pai o tō urupare.
Kaua rawa e mutu te tango tildrakizumab ohorere me te kore e kōrero tuatahi ki tō tākuta. Ko te whakamutu ohorere ka puta pea te hokinga mai, te kino rānei o ō tohu psoriasis.
Pērā i ngā rongoā katoa, ka taea e te tildrakizumab te pānga taha, ahakoa kāore te katoa e pā ana ki a rātou. Ko te nuinga o ngā pānga taha he ngawari ki te āhua, ā, ka taea te whakahaere mā te aroturuki tika.
Anei ngā pānga taha tino noa ka pā pea ki a koe:
Ko ēnei pānga taha noa ka pai ake i te wā e whakatika ana tō tinana ki te rongoā, ā, ka taea e te nuinga o te tangata te haere tonu i tā rātou rongoā me te kore e aukati.
Ko ētahi pānga taha kāore i te noa engari he nui ake te kino e hiahia ana kia āta tirohia e te tākuta:
Ko ngā pānga taha kāore i te noa engari he kino ka uru pea ki te piki ake o te tūponotanga o ētahi mate, ngā pānga rānei ki tō mahi ate. Ka āta tirohia koe e tō tākuta i ngā wā katoa mā ngā whakamātautau toto kia kitea wawe ai ngā raruraru.
Kāore a Tildrakizumab i te tika mō te katoa, ā, ko ētahi āhuatanga hauora, āhuatanga rānei ka kore e tika, ka hiahia rānei kia tūpato.
Kāore koe e tika kia tango tildrakizumab mēnā he mate kino tō tinana i tētahi wāhi. Kei roto i tēnei ko ngā mate huakita, huaketo, harore, parataiao rānei kāore anō kia rongoatia, kia whakatauhia.
Ko ngā tāngata e whai ana i ētahi āhuatanga hauora me āta arotake i mua i te tīmatanga o te tildrakizumab:
Me āta arotake e tō tākuta ēnei āhuatanga nā te mea ka pā a tildrakizumab ki tō pūnaha ārai mate, ā, ka kino ake pea ētahi raruraru hauora.
Me mātua te hapū me te whāngai ū. Ahakoa he iti noa ngā raraunga mō te haumaru o te tildrakizumab i te wā e hapū ana, me kōrero koe i ngā tūponotanga me ngā painga ki tō tākuta mēnā kei te hapū koe, kei te whakamahere rānei koe ki te hapū, kei te whāngai ū rānei.
Ko te ingoa waitohu mō te tildrakizumab ko Ilumya. Koinei te ingoa ka kite koe i runga i te pounamu rongoā me te pōkai rongoā.
He mea hanga a Ilumya e Sun Pharmaceutical Industries, ā, i whakaaetia e te FDA i te tau 2018 mō te rongoā i te psoriasis pātea mō te hunga pakeke. Koinei anake te putanga ingoa waitohu o te tildrakizumab e wātea ana i tēnei wā.
I te kōrero ki tō tākuta, ki tō kai rongoā rānei, ka taea e koe te kī i tō rongoā ko tildrakizumab, ko Ilumya rānei - he rongoā kotahi tonu. Ka whakamahi pea tō inihua me tō whare rongoā i tētahi ingoa i te wā e tukatuka ana i tō rēhitatanga.
He maha atu ngā rongoā koiora e mahi ana i te rite ki te tildrakizumab mō te rongoā i te psoriasis. E whāia ana e ēnei kōwhiringa kē ngā pūmua rerekē i roto i te pūnaha ārai mate engari e whai ana ki te whakatutuki i ngā hua rite.
Ko ētahi atu aukati IL-23 pēnei i te tildrakizumab ko guselkumab (Tremfya) me risankizumab (Skyrizi). E mahi ana ēnei rongoā mā te ara kotahi, ā, he rite tonu te whai huatanga me ngā pūkete pānga taha.
Ko ētahi atu kōwhiringa kē koiora e whāia ana ngā ara rerekē o te pūnaha ārai mate:
Mā tō tākuta koe e āwhina ki te whiriwhiri i te kōwhiringa pai rawa atu i runga i tō āhuatanga motuhake, te hītori hauora, me te pēhea i urupare ai koe ki ngā rongoā o mua. He rārangi inenga, he pūkete pānga taha, me ngā whakaaronga anō tō ia rongoā.
He pai te tildrakizumab me te adalimumab hei rongoā mō te psoriasis, engari he rerekē ā rāua mahi, ā, he rerekē ngā painga. Ko te kōwhiringa "pai ake" ka whakawhirinaki ki ō hiahia me tō āhuatanga hauora.
E whāia ana e Tildrakizumab te IL-23, ā, e aukati ana a adalimumab i te TNF-alpha. E ai ki ngā rangahau haumanu, tērā pea ka whai hua ake a tildrakizumab ki te whakatutuki i te kiri mārama, tata rānei te mārama i ētahi tāngata, inā rā ko te hunga e pā ana ki te psoriasis āhua nui, nui rānei.
He rerekē te wāhanga inenga i waenga i ēnei rongoā. Ka hoatu a Tildrakizumab ia 12 wiki i muri i ngā inenga tuatahi, ā, ko te adalimumab te tikanga me werohia ia wiki kē. Ko tēnei inenga iti ake te auau ki te tildrakizumab tērā pea ka pai ake mō ētahi tāngata.
He rerekē anō ngā āhuatanga o ngā pānga taha i waenga i ngā rongoā e rua. Kua roa te wā e wātea ana a Adalimumab, ā, he nui ake ngā raraunga tūturu, ā, he hou ake a tildrakizumab, tērā pea he iti ake ngā pānga rongoā me ngā pānga ki te pūnaha ārai mate whānui.
Ka taea te whakamahi i te tildrakizumab i roto i te hunga mate huka, engari me mātakitaki koe e tō tākuta. Tērā pea ka nui ake te tūponotanga o te mate i te hunga mate huka, ā, ka pā anō te tildrakizumab ki te kaha o tō pūnaha ārai mate ki te whawhai i ngā mate.
Tērā pea ka hiahia tō tākuta ki te whakarite kia pai te whakahaere i tō mate huka i mua i te tīmatanga o te tildrakizumab. Tērā pea ka tūtohu rātou kia nui ake ngā arotake hei mātakitaki i ngā tohu o te mate, ētahi atu raruraru rānei.
Mēnā ka werohia e koe te nui rawa o te tildrakizumab i te mea i whakaritea, whakapā atu ki tō tākuta, ki tō kaiwhakarato hauora rānei i te wā tonu. Ahakoa he onge te nui rawa o te tildrakizumab nā te hoahoa o te syringe kua whakakiia, he mea nui kia whiwhi tohutohu hauora.
Kaua e ngana ki te utu mā te karo i tō horopeta e whai ake nei, te huri rānei i tō hōtaka i runga i a koe anō. Ka tohutohu tō tākuta i a koe me pēhea te haere haumaru, ā, tērā pea ka hiahia rātou ki te aroturuki i a koe kia mātātoa ake mō ngā pānga taha.
Mēnā kua ngaro i a koe tētahi horopeta tūtohu o tildrakizumab, tangohia i te wā e mahara ana koe. Katahi ka haere tonu ki tō hōtaka horopeta auau mai i taua wā tonu.
Kaua e rua ngā horopeta, e ngana rānei ki te utu i te horopeta kua ngaro mā te tango rongoā atu. Whakapā atu ki te tari o tō tākuta mēnā kāore koe i te mōhio mō te wā, mēnā rānei kua ngaro i a koe ngā horopeta maha, nā te mea tērā pea me whakatika e rātou tō hōtaka maimoatanga.
Me mutu anake tō tango tildrakizumab i raro i te tohutohu a tō tākuta. I te mea he āhuatanga tawhito te psoriasis, ka puta anō pea ō tohumate i te wā e mutu ana te rongoā.
Tērā pea ka tūtohu tō tākuta kia mutu te tango tildrakizumab mēnā ka pā ki a koe ngā pānga taha nui, ka whanake i ētahi mate, mēnā rānei kua pai te whakahaere i tō psoriasis mō tētahi wā roa. Ka mahi rātou i a koe ki te whakawhanake i tētahi mahere mō te aroturuki i tō āhuatanga i muri i te whakamutu i te rongoā.
Ka taea e koe te whiwhi i te nuinga o ngā kano ārai mate i te wā e tango ana i te tildrakizumab, engari me karo e koe ngā kano ārai mate ora. Ka tūtohu tō tākuta kia whai wāhi ki ngā kano ārai mate katoa e tika ana i mua i te tīmatanga o te maimoatanga i te wā e taea ana.
Ko ngā kano ārai mate noa pēnei i te pū o te rewharewha, ngā kano ārai mate COVID-19, me ētahi atu kano ārai mate whakakorehia te mahi, he haumaru te whiwhi i te wā e tango ana i te tildrakizumab. Heoi, whakamōhio tonu ki tō kaiwhakarato hauora kei te tango koe i tēnei rongoā i mua i te whiwhi i tētahi kano ārai mate.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.